PDCD1 and cancer: The breakthrough discovery of immune checkpoints such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death 1 (PD-1) had led to the development of immune checkpoint inhibitors (ICI) resulting in substantial changes in cancer treatment paradigms.